Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

New ICD receives CE Mark approval

Boston Scientific : 09 October, 2007  (New Product)
Boston Scientific has received CE Mark approval for its Confient implantable cardioverter defibrillator (ICD).
This approval represents the first Boston Scientific branded cardiac rhythm management device to treat sudden cardiac death (SCD).

Boston Scientific has announced CE Mark approval of its Confient
implantable cardioverter defibrillator (ICD). This approval represents the
first Boston Scientific-branded cardiac rhythm management device to treat
sudden cardiac death (SCD).

The Confient ICD, with an enhanced AV Search Hysteresis feature, is designed
to reduce unnecessary right ventricular pacing. The product also contains
wireless capability that is designed to save physicians time during implant
by allowing device programming during wound closure while also eliminating
the need for the wand in the sterile field. The device also saves time at follow-up
with device interrogations that can be three times faster than the company's
wanded telemetry.

'The Confient ICD is a tangible example of our Cardiac Rhythm Management
group's ability to deliver meaningful product innovation,' said Jim Tobin,
president and chief executive officer of Boston Scientific. 'We look forward
to making this ICD broadly available to physicians so they can offer this
advanced therapy to patients who are at risk of sudden cardiac death.'

The Confient ICD is not available for sale in the USA.

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo